Akanda Corp. (AKAN) Stock Analysis & Investment Frameworks
Akanda Corp. (AKAN) stock analysis on Invetso. Review Akanda Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Akanda Corp. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Country: CA
Akanda Corp. Key Financial Metrics
- Market Cap: $99364.00
- Revenue: $258075.00
- ROE: 1217.88%
- ROIC: -232.42%
- Dividend Yield: N/A
About Akanda Corp.
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Akanda Corp. Investment Frameworks
Invetso analyzes Akanda Corp. (AKAN) across the following frameworks:
- Akanda Corp. 10Y Growth Potential
- Akanda Corp. Scenario Analysis
- Akanda Corp. Risks & Opportunities
- Akanda Corp. Economic Moat
- Akanda Corp. Business Model
- Akanda Corp. Management
- Akanda Corp. SWOT Analysis
- Akanda Corp. Porter's 5 Forces
- Akanda Corp. PESTLE Analysis
- Akanda Corp. ESG Analysis
